Patents Assigned to Procure Therapeutics Limited
  • CANCER VACCINE
    Publication number: 20120100102
    Abstract: We disclose a vaccine comprising a pappalysin and vaccine compositions comprising a pappalysin.
    Type: Application
    Filed: June 22, 2010
    Publication date: April 26, 2012
    Applicant: PROCURE THERAPEUTICS LIMITED
    Inventor: Richard Birnie
  • Prostate stem cell
    Patent number: 8153421
    Abstract: We describe a method for the isolation of prostate stem cells, typically prostate stem cells which express CD 133 antigen; stem cells and cancer stem cells isolated by the method and their use.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: April 10, 2012
    Assignee: Procure Therapeutics Limited
    Inventors: Norman James Maitland, Anne Collins
  • Stem Cell Markers
    Publication number: 20090012024
    Abstract: We disclose gene markers of stem cells, typically prostate stem cells, and in particular cancer stem cells, for example prostate cancer stem cells; therapeutic agents and diagnostic assays based on said stem cell genes; and including screening assays to identify therapeutic agents.
    Type: Application
    Filed: July 19, 2006
    Publication date: January 8, 2009
    Applicant: Procure Therapeutics Limited
    Inventors: Anne Collins, Norman Maitland, Steven Bryce
  • Prostate Stem Cell
    Publication number: 20080233640
    Abstract: We describe a method for the isolation of prostate stem cells, typically prostate stem cells which express CD 133 antigen; stem cells and cancer stem cells isolated by the method and their use.
    Type: Application
    Filed: March 18, 2005
    Publication date: September 25, 2008
    Applicant: Procure Therapeutics Limited
    Inventors: Norman James Maitland, Anne Collins
  • Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide
    Patent number: 7393524
    Abstract: The invention relates to a genetically engineered baculovirus wherein said virus is engineered to target therapeutic agents to cells, typically cancer cells, for example prostate cancer cells.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: July 1, 2008
    Assignee: Procure Therapeutics Limited
    Inventor: Norman Maitland